Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.19 | 4.23 |
| PEG Ratio (TTM) | 0.04 | 1.23 |
| P/S Ratio (TTM) | 0.05 | 1.33 |
| P/B Ratio (TTM) | -0.07 | 2.34 |
| P/FCF Ratio (TTM) | -0.66 | 20.31 |
| Price to 5YR AVG Earnings Ratio | -0.79 | -85.69 |
| Price to 5YR AVG FCF Ratio | -7.45 | 18.60 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -23.44% | 1.29% |
| ROE (TTM) | 38.70% | 19.53% |
| Net Profit Margin (TTM) | -24.97% | 2.19% |
| ROIC 5YR AVG | 2.23% | 20.08% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -70.17% | 259,982.33% | 155,882.15% |
| Revenue | -3.75% | N/A | 3.95% |
| Net Income | -26.84% | 9,784.60% | 5,757.51% |
| Cash Flow | -0.63% | 1,113.86% | 167.67% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.15 | 1.20 |
| Quick Ratio (TTM) | 1.15 | 1.16 |
| D/E Ratio (TTM) | -2.57 | 1.02 |
| Interest Coverage (TTM) | -3.17 | 4.82 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | 0.13 | 2.15 |
| LTL to 5YR AVG FCF | -255.43 | 5.73 |
| Shares Outstanding Growth 5YR AVG | -9.74% | 2.32% |